Patents by Inventor Debra Barrett

Debra Barrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8399495
    Abstract: Novel metabolites of talarazole of formula (I) have been isolated and characterized, wherein R?H, OH, OSO3H or O-gly; R1, ?H, OH, OSO3H, O-gly or =0; and gly=a glucuronate, or a pharmaceutically acceptable salt thereof. These compounds are targeted for the treatment of various skin-, hair- and nail-associated disorders.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: March 19, 2013
    Assignee: Stiefel Laboratories, Inc.
    Inventor: Debra Barrett
  • Publication number: 20120283204
    Abstract: Novel metabolites of talarazole of formula (I) have been isolated and characterized, wherein R?H, OH, OSO3H or O-gly; R1, ?H, OH, OSO3H, O-gly or =0; and gly=a glucuronate, or a pharmaceutically acceptable salt thereof. These compounds are targeted for the treatment of various skin-, hair- and nail-associated disorders.
    Type: Application
    Filed: May 21, 2012
    Publication date: November 8, 2012
    Inventor: Debra BARRETT
  • Patent number: 8188124
    Abstract: Novel metabolites of talarazole of formula (I) have been isolated and characterized, wherein R?H, OH, OSO3H or O-gly; R1, ?H, OH, OSO3H, O-gly or =0; and gly=a glucuronate, or a pharmaceutically acceptable salt thereof. These compounds are targeted for the treatment of various skin-, hair- and nail-associated disorders.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: May 29, 2012
    Assignee: Stiefel Laboratories, Inc.
    Inventor: Debra Barrett
  • Publication number: 20100292284
    Abstract: Novel metabolites of talarazole of formula (I) have been isolated and characterized, wherein R?H, OH, OSO3H or O-gly; R1, ?H, OH, OSO3H, O-gly or =0; and gly=a glucuronate, or a pharmaceutically acceptable salt thereof. These compounds are targeted for the treatment of various skin-, hair- and nail-associated disorders.
    Type: Application
    Filed: October 17, 2007
    Publication date: November 18, 2010
    Applicant: Stiefel Laboratories, Inc.
    Inventor: Debra Barrett